News
Filters
Showing 1 - 3 out of 3 results
Article
Witnessing a breakthrough: physicians find hope in new Alzheimer’s drug
For neurologists working with patients with Alzheimer’s disease, the road to actual treatment options has been long and paved with setbacks.
But that is changing for some patients. The Food and Drug Administration recently granted full approval to Leqembi® (lecanemab), the first disease-modifying treatment fully approved for patients in the early stages of Alzheimer’s disease. The development of this new drug offers hope to patients and may have lasting impacts on how physicians approach treatment.
Article
Helping Your Knees Age
What’s the most common health concern for people over 65?
Article
Diabetes and the COVID-19 Vaccine: What you need to know
Now that three COVID-19 vaccines have been authorized for use, questions are circulating about the vaccines’ safety and effectiveness, and if and when those with certain health conditions, such as diabetes, should get vaccinated.